HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Albano Selected Research

Caspase 3 (Caspase-3)

10/2014Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme.
4/2013Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Albano Research Topics

Disease

21BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2022 - 04/2007
17Neoplasms (Cancer)
02/2022 - 10/2008
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 03/2008
11Leukemia
01/2022 - 03/2013
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 10/2004
7Acute Promyelocytic Leukemia
01/2021 - 03/2006
6Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 06/2010
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 03/2002
6Philadelphia Chromosome
01/2021 - 08/2017
4Residual Neoplasm
01/2021 - 10/2004
4Melanoma (Melanoma, Malignant)
09/2020 - 04/2013
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2020 - 03/2014
4Lymphoma (Lymphomas)
01/2019 - 09/2014
3Disease Progression
12/2021 - 10/2017
2Eosinophilia
02/2022 - 11/2019
2Hematologic Diseases (Blood Diseases)
01/2022 - 12/2019
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 03/2013
2Multiple Myeloma
09/2020 - 10/2017
2B-Cell Lymphoma (Lymphoma, B Cell)
09/2020 - 01/2016
2Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2020 - 01/2020
2Genetic Translocation (Chromosomal Translocation)
09/2014 - 10/2008
2Mitochondrial Diseases (Mitochondrial Disease)
04/2013 - 01/2010
1Pheochromocytoma
05/2022
1Second Primary Neoplasms (Neoplasms, Second)
03/2022
1Chromosome Aberrations (Chromosome Abnormalities)
02/2022
1Bronchiolitis Obliterans Syndrome
01/2022
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Genomic Instability
12/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2021
1Dyslipidemias (Dyslipidemia)
08/2021
1Carcinogenesis
07/2021
1Lymphoid Leukemia
07/2021
1Chronic Disease (Chronic Diseases)
05/2021
1Fatigue
05/2021
1Fatty Liver
10/2020
1Thyroid Neoplasms (Thyroid Cancer)
09/2020
1Carcinoma (Carcinomatosis)
09/2020
1Hypertension (High Blood Pressure)
07/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020

Drug/Important Bio-Agent (IBA)

15Tyrosine Kinase InhibitorsIBA
01/2021 - 03/2013
10Biological ProductsIBA
03/2022 - 03/2006
8Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 04/2007
6nilotinibFDA Link
10/2022 - 03/2013
5Pharmaceutical PreparationsIBA
07/2020 - 01/2010
4Phosphotransferases (Kinase)IBA
01/2021 - 01/2013
4Dasatinib (BMS 354825)FDA Link
01/2019 - 01/2013
3Biomarkers (Surrogate Marker)IBA
07/2021 - 10/2017
3fludarabineIBA
11/2020 - 02/2014
3ponatinibIBA
01/2020 - 01/2019
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 02/2017
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
02/2022 - 02/2008
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022 - 01/2021
2LDL Lipoproteins (beta Lipoproteins)IBA
08/2021 - 01/2020
2MicroRNAs (MicroRNA)IBA
07/2021 - 08/2012
2Arsenic Trioxide (Trisenox)FDA Link
01/2020 - 02/2017
2Peptides (Polypeptides)IBA
10/2017 - 01/2016
2Proteins (Proteins, Gene)FDA Link
11/2015 - 10/2014
2Untranslated RNA (Noncoding RNA)IBA
10/2015 - 10/2008
2AntigensIBA
12/2014 - 03/2002
2Caspase 3 (Caspase-3)IBA
10/2014 - 04/2013
2Superoxide DismutaseIBA
04/2013 - 01/2010
2Diclofenac (SR 38)FDA LinkGeneric
04/2013 - 01/2010
13-Iodobenzylguanidine (Iobenguane)IBA
05/2022
1CatecholaminesIBA
05/2022
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2022
1Messenger RNA (mRNA)IBA
01/2022
1ibrutinibIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1fms-Like Tyrosine Kinase 3IBA
01/2022
1Interferon Regulatory FactorsIBA
12/2021
1Tryptophan (L-Tryptophan)FDA Link
12/2021
1Nuclear Export Signals (Nuclear Export Signal)IBA
12/2021
1Protein CIBA
12/2021
1NucleophosminIBA
12/2021
1oxidized low density lipoproteinIBA
08/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2021
1Cell-Free Nucleic AcidsIBA
07/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1ofatumumabFDA Link
11/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020
1EnzymesIBA
10/2020
1Lenalidomide (CC 5013)FDA Link
09/2020
1Immunomodulating AgentsIBA
09/2020
1Angiotensin Receptor AntagonistsIBA
07/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2020
1HMGA ProteinsIBA
06/2020
1Nucleic AcidsIBA
04/2020
1Immunoglobulin Variable RegionIBA
03/2020
1carboxyl radical (COO-)IBA
01/2020

Therapy/Procedure

21Therapeutics
07/2021 - 03/2008
5Drug Therapy (Chemotherapy)
12/2021 - 01/2016
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2022 - 03/2013
3Precision Medicine
12/2021 - 10/2017
3Transplantation
11/2021 - 03/2013
3Aftercare (After-Treatment)
01/2020 - 04/2007
1Homologous Transplantation
11/2021
1Stem Cell Transplantation
11/2021